Mechanistic analysis revealed that NPC1 overexpression promotes HCC progression by enhancing neutrophil recruitment, positioning NPC1 as a promising biomarker and therapeutic target for HCC (Yang et al., 2024). The gene discussed is NPC1; the disease is hepatocellular carcinoma.